EDIT FY 2020 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$91M+341.9% YoY

Gross Profit

-$67M-74.1% margin

Operating Income

-$135M-148.6% margin

Net Income

-$116M-127.8% margin

EPS (Diluted)

$-1.98

Cash Flow

Operating Cash Flow

-$180M

Free Cash Flow

-$187M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$573M

Total Liabilities

$179M

Stockholders' Equity

$394M

Cash & Equivalents

$140M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$91M	$21M	+341.9%
Gross Profit	-$67M	-$76M	+11.9%
Operating Income	-$135M	-$141M	+4.3%
Net Income	-$116M	-$134M	+13.3%